ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 109 filers reported holding ENZO BIOCHEM INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $153,000 | +39.1% | 22,070 | +2.0% | 0.00% | – |
| Q3 2016 | $110,000 | -7.6% | 21,638 | +8.5% | 0.00% | – |
| Q2 2016 | $119,000 | +221.6% | 19,949 | +148.5% | 0.00% | – |
| Q1 2016 | $37,000 | +2.8% | 8,028 | 0.0% | 0.00% | – |
| Q4 2015 | $36,000 | +44.0% | 8,028 | 0.0% | 0.00% | – |
| Q3 2015 | $25,000 | +4.2% | 8,028 | 0.0% | 0.00% | – |
| Q2 2015 | $24,000 | -67.1% | 8,028 | -67.5% | 0.00% | – |
| Q1 2015 | $73,000 | -25.5% | 24,708 | +11.9% | 0.00% | – |
| Q4 2014 | $98,000 | -14.0% | 22,084 | 0.0% | 0.00% | – |
| Q3 2014 | $114,000 | -4.2% | 22,084 | -2.2% | 0.00% | – |
| Q2 2014 | $119,000 | +260.6% | 22,585 | +181.3% | 0.00% | – |
| Q1 2014 | $33,000 | +43.5% | 8,028 | 0.0% | 0.00% | – |
| Q4 2013 | $23,000 | +15.0% | 8,028 | 0.0% | 0.00% | – |
| Q3 2013 | $20,000 | +17.6% | 8,028 | 0.0% | 0.00% | – |
| Q2 2013 | $17,000 | – | 8,028 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,392,642 | $6,939,000 | 11.21% |
| VIEX Capital Advisors, LLC | 1,435,130 | $4,162,000 | 7.44% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $15,010,000 | 6.29% |
| Potomac Capital Management, Inc. | 496,805 | $1,441,000 | 1.24% |
| AMH Equity Ltd | 30,000 | $87,000 | 0.09% |
| Corsair Capital Management | 75,026 | $218,000 | 0.05% |
| RBF Capital, LLC | 250,359 | $730,000 | 0.05% |
| KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $74,000 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 539,954 | $1,566,000 | 0.04% |
| Cutter & CO Brokerage, Inc. | 25,777 | $75,000 | 0.02% |